Investors might want to bet on AVROBIO, Inc. (AVRO), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one ...
AVROBIO, Inc. (AVRO) has been beaten down lately with too much selling pressure. While the stock has lost 19.7% over the past four weeks, there is light at the end of the tunnel as it is now in ...
The average one-year price target for AvroBio (NASDAQ:AVRO) has been revised to 3.74 / share. This is an increase of 12.82% from the prior estimate of 3.32 dated August 31, 2023. The price target is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results